Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
Blood Cancer Journal
|
March 9, 2013
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
A Tefferi, O Abdel-Wahab, F Cervantes, et al.
Leukemia
|
February 8, 2014
Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
G Jego, D Lanneau, A De Thonel, et al.
Blood Cancer Journal
|
May 13, 2017
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
M Duchmann, T Braun, J-B Micol, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Blood Cancer Journal
|
August 1, 2015
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
E Padron, G Garcia-Manero, M M Patnaik, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Leukemia
|
September 13, 2014
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
X Cabagnols, J P Defour, V Ugo, et al.
Leukemia
|
April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
F Maloisel, A Guerci, D Guyotat, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
Blood Cancer Journal
|
March 9, 2013
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
A Tefferi, O Abdel-Wahab, F Cervantes, et al.
Leukemia
|
February 8, 2014
Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
G Jego, D Lanneau, A De Thonel, et al.
Blood Cancer Journal
|
May 13, 2017
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
M Duchmann, T Braun, J-B Micol, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Blood Cancer Journal
|
August 1, 2015
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
E Padron, G Garcia-Manero, M M Patnaik, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Leukemia
|
September 13, 2014
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
X Cabagnols, J P Defour, V Ugo, et al.
Leukemia
|
April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
F Maloisel, A Guerci, D Guyotat, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Page
of 17